Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate

Analytical Biochemistry

Volumn 340, Issue 1, 2005, Pages 106-112

  Willemse, Johan ^a   Leurs, Judith ^a   Verkerk, Robert ^a   Hendriks, Dirk ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Arginine kinase; Assay; Bradykinin; Carboxypeptidase U; Kinetic; TAFI

Indexed keywords

ARGININE; ASSAYS; ENZYMES; PEPTIDES; PHYSIOLOGICAL MODELS; SUBSTRATES;

ARGININE KINASE; BRADYKININ; CARBOXYPEPTIDASE; INTRINSIC INSTABILITY; LACTATE DEHYDROGENASE; PHYSIOLOGICAL SUBSTRATE; SUBSTRATE SPECIFICITY; TAFI;

KINETICS;

ARGININE; ARGININE KINASE; BRADYKININ; LACTATE DEHYDROGENASE; PYRUVATE KINASE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ANALYTIC METHOD; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME KINETICS; ENZYME RELEASE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 15544373731     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2005.01.039     Document Type: Article

References (34)

1. R.A. Skidgel Structure and function of mammalian zinc carboxypeptidases N.M. Hooper Zinc Metalloproteases in Health and Disease 1996 Taylor & Francis London 241 283
2. D. Hendriks, S. Scharpé, and M. van Sande Partial characterization of a new arginine carboxypeptidase from human serum J. Clin. Chem. Clin. Biochem. 26 1988 305
3. D. Hendriks, S. Scharpé, M. van Sande, and M.P. Lommaert Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N J. Clin. Chem. Clin. Biochem. 27 1989 277 285
4. W. Wang, M.B. Boffa, L. Bajzar, J.B. Walker, and M.E. Nesheim A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor J. Biol. Chem. 273 1998 27176 27181
5. M. Schneider, and M. Nesheim A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis J. Biol. Chem. 279 2004 13333 13339
6. J. Leurs, V. Nerme, Y. Sim, and D. Hendriks Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism J. Thromb. Haemost. 2 2004 416 423
7. J.B. Walker, and L. Bajzar The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin activable fibrinolyis inhibitor is masked by its instability J. Biol. Chem. 279 2004 27896 27904
8. M.B. Boffa, W. Wang, L. Bajzar, and M.E. Nesheim Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin dependent activation, thermal stability, and enzymatic properties J. Biol. Chem. 278 2003 32359 32366
9. D. Hendriks, S. Scharpé, M. van Sande, and M.P. Lommaert A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N Clin. Chem. 35 1989 177
10. M. Schneider, M. Boffa, R. Stewart, M. Rahman, M. Koschinsky, and M. Nesheim Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme J. Biol. Chem. 277 2002 1021 1030
11. P.F. Marx, T.M. Hackeng, P.E. Dawson, J.H. Griffin, J.C. Meijers, and B.N. Bouma Inactivation of active thrombin activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage J. Biol. Chem. 275 2000 12410 12415
12. M.B. Boffa, R. Bell, W.K. Stevens, and M.E. Nesheim Roles of thermal instability and proteolytic cleavage in regulation of thrombin-activable fibrinolysis inhibitor J. Biol. Chem. 275 2000 12868 12878
13. J.B. Walker, B. Hughes, I. James, P. Haddock, C. Kluft, and L. Bajzar Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro J. Biol. Chem. 278 2003 8913 8921
14. P.F. Marx, B.N. Bouma, and J.C. Meijers Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor Biochemistry 41 2002 1211 1216
15. K. Schatteman, F. Goossens, S. Scharpé, and D. Hendriks Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma Clin. Chem. 45 1999 807 813
16. A.I. Vogel Practical Organic Chemistry 1970 Longman London
17. K. Schatteman, F. Goossens, S. Scharpé, and D. Hendriks Proteolytic activation of purified procarboxypeptidase U Clin. Chim. Acta 292 2000 25 40
18. R. France, D. Sellers, and S. Grossman Purification, characterization, and hydrodynamic properties of arginine kinase from Gulf shrimp (Penaeus aztecus) Arch. Biochem. Biophys. 345 1997 73 78
19. U. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
20. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 258
21. C. Konings A kinetic procedure for the estimation of arginine in serum using arginine kinase Clin. Chim. Acta 176 1988 185 194
22. M. Strömqvist, K. Schatteman, J. Leurs, R. Verkerk, J.O. Andersson, T. Johansson, S. Scharpé, and D. Hendriks Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma Thromb. Haemost. 85 2001 12 17
23. L. Juillerat-Jeanneret, M. Roth, and J.P. Bargetzi Some properties of porcine carboxypeptidase N Hoppe-Seyler's Z. Physiol. Chem. 363 1982 51 58
24. K. Masuda, M. Yoshioka, D. Hinode, and R. Nakamura Purification and characterization of arginine carboxypeptidase produced by Porphyromonas gingivalis Infect. Immunol. 70 2002 1807 1815
25. L. Bajzar, R. Manuel, and M. Nesheim Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor J. Biol. Chem. 270 1995 14477 14484
26. W. Wang, D. Hendriks, and S. Scharpé Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen J. Biol. Chem. 269 1994 15937 15944
27. J. Leurs, B.M. Wissing, V. Nerme, K. Schatteman, P. Bjorquist, and D. Hendriks Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma Thromb. Haemost. 89 2003 264 271
28. M. Nesheim, J. Walker, W. Wang, M. Boffa, A. Horrevoets, and L. Bajzar Modulation of fibrin cofactor activity in plasminogen activation Ann. NY Acad. Sci. 936 2001 247 260
29. T. Myles, T. Nishimura, T.H. Yun, M. Nagashima, J. Morser, A.J. Patterson, R.G. Pearl, and L.L.K. Leung Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation J. Biol. Chem. 278 2003 51059 51067
30. T. Sato, T. Miwa, H. Akatsu, N. Matsukawa, K. Obata, N. Okada, W. Campbell, and H. Okada Procarboxypeptidase R is an acute phase protein in mouse, whereas carboxypeptidase N is not J. Immunol. 165 2000 1053 1058
31. W.D. Campbell, E. Lazoura, N. Okada, and H. Okada Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N Microbiol. Immunol. 46 2002 131 134
32. K. Schatteman, F. Goossens, J. Leurs, Y. Kasahara, S. Scharpé, and D. Hendriks Fast and homogeneous assay for plasma procarboxypeptidase U Clin. Chem. Lab. Med. 39 2001 806 810
33. J.D. Cooper, D.C. Turnell, B. Green, and F. Verillon Automated sequential trace enrichment of dialysates and robotics: a technique for the preparation of biological samples prior to high-performance liquid chromatography J. Chromatogr. 456 1988 53 69
34. D.C. Turnell, and J.D. Cooper Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography Clin. Chem. 28 1982 527 531